36C24419Q0848-000.docx

DOCX document 14 KB Posted

Attached to
Notice of Intent to Sole Source to Accredo Health Group Inc
Solicitation number
36C24419Q0848
Issued by

About this file

36C24419Q0848 36C24419Q0848.docx

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

FedBizOpps Special Notice

CLASSIFICATION CODE

SUBJECT

CONTRACTING OFFICE'S

ZIP-CODE

SOLICITATION NUMBER

ARCHIVE

DAYS AFTER THE RESPONSE DATE

RECOVERY ACT FUNDS

NAICS CODE

CONTRACTING OFFICE

ADDRESS

POINT OF CONTACT

(POC Information Automatically Filled from User Profile Unless Entered)

DESCRIPTION

See Attachment

AGENCY'S URL

URL DESCRIPTION

AGENCY CONTACT'S EMAIL

ADDRESS

EMAIL DESCRIPTION

GENERAL INFORMATION

ADDITIONAL INFORMATION

* = Required Field FedBizOpps Special Notice Rev. March 2010 Notice of Intent to Sole Source to Accredo Health Group Inc 15215 36C24419Q0848 N 446110 Department of Veterans Affairs Network Contracting Office 4 1010 Delafield Road Pittsburgh, PA 15215 Justin Erdley justin.erdley@va.gov justin.erdley@va.gov Notice of Intent to Sole Source

The Lebanon VA Medical Center (LVAMC), 1700 South Lincoln Avenue, Lebanon Pennsylvania 17042 has an urgent request for Oxervate Ophthalmic solution medication. This urgent request is to treat corneal ulcers to prevent blindness. VA has only located one vendor capable of providing Oxervate and intends to issue a sole source contract to that vendor.

This notice is being posted so that any unknown vendors who are capable of providing this item may come forward and express their interest and capability in providing Oxervate to VA. If your company/organization is capable of providing the required item, provide your entities capability statement to Justin Erdley, Contract Specialist by 06/26/2019 4:00 PM EST via email to justin.erdley@va.gov. In addition to your capability statement also provide any applicable distribution agreements regarding Oxervate, the size and socioeconomic status of your company, and any other information pertinent to this requirement. Reference Procurement ID number 36C24419Q0848 in the subject of the email.

***This is not a request for quote, no quotes should be sent in response to this notice.

Statement of Need:

Product needed: One 56ml bottle liquid of Oxervate Opthalmic Solution

Performance Requirement:

a.
Common Nomenclature (commercial description):

Medication

b.
Kind of material (i.e., type, grade, alternatives, etc.):
Liquid
c.
Electrical Data (i.e., 110 v, 60 Hz, 3 Ph, etc.):

N/A

d.
Dimensions, size, capacity:
56 ml bottle
e.
Principles of operation:

Will be utilized for the treatment of corneal abrasions

f.
Restrictive environmental conditions:

N/A

g.
Intended use:

Treatment of corneal abrasions

j.
Original equipment manufacturer part number:
NDC #: 71981-020

Delivery:

Medication is shipped directly to the patient.

End of Document

End of Document

File details come from the government source that posted it.